Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Saul Marquez. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Saul Marquez or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Pioneering Obesity Treatment with Medication and Lifestyle Transformation with Rob MacNaughton, CEO of Calibrate

13:35
 
Share
 

Manage episode 479837996 series 2893730
Content provided by Saul Marquez. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Saul Marquez or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

The future of obesity treatment lies in combining powerful drug therapies with clinician-led lifestyle interventions.

In this episode, Rob MacNaughton, CEO of Calibrate, discusses the company’s pioneering approach to weight management. He shares how Calibrate blends anti-obesity medications with clinician-led lifestyle interventions to ensure sustainable weight loss outcomes. This model not only helps individuals maintain weight loss but also drives better healthcare outcomes while reducing costs. Rob highlights Calibrate’s commitment to clinical integrity and ongoing research into tapering medication and long-term success, providing valuable insights into the future of obesity treatment.

Tune in and learn how combining medication with lifestyle changes is transforming obesity treatment and delivering lasting health benefits.

Resources:

Connect with and follow Rob MacNaughton on LinkedIn.

Follow Calibrate on LinkedIn and explore their website.

  continue reading

2042 episodes

Artwork
iconShare
 
Manage episode 479837996 series 2893730
Content provided by Saul Marquez. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Saul Marquez or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

The future of obesity treatment lies in combining powerful drug therapies with clinician-led lifestyle interventions.

In this episode, Rob MacNaughton, CEO of Calibrate, discusses the company’s pioneering approach to weight management. He shares how Calibrate blends anti-obesity medications with clinician-led lifestyle interventions to ensure sustainable weight loss outcomes. This model not only helps individuals maintain weight loss but also drives better healthcare outcomes while reducing costs. Rob highlights Calibrate’s commitment to clinical integrity and ongoing research into tapering medication and long-term success, providing valuable insights into the future of obesity treatment.

Tune in and learn how combining medication with lifestyle changes is transforming obesity treatment and delivering lasting health benefits.

Resources:

Connect with and follow Rob MacNaughton on LinkedIn.

Follow Calibrate on LinkedIn and explore their website.

  continue reading

2042 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play